Skip to content
Back to glossary
Biomarkers

Lp(a) (Lipoprotein(a))

Lipoprotein(a), or Lp(a), is an LDL-like particle. In it, apolipoprotein(a) is covalently linked to apoB-100 through a disulfide bond. Your plasma level is largely genetic (often cited around 70 to 90%) and usually stable across adulthood, though it can shift modestly with menopause, kidney disease, or inflammation. Mendelian randomization at the LPA gene supports a causal role for high Lp(a) in heart attack, ischemic stroke, and calcific aortic valve narrowing. Because diet and lifestyle barely move it, you should measure Lp(a) at least once, to gauge your lifetime cardiovascular risk. Per the EAS 2022 thresholds, a rule-in risk level is above 50 mg/dL (above 125 nmol/L), and a rule-out level is below 30 mg/dL (below 75 nmol/L).

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Kronenberg F, Mora S, Stroes ES, Ference BA, Arsenault BJ, Berglund L, et al.. (2022). Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. *European Heart Journal*doi:10.1093/eurheartj/ehac361
  2. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, et al.. (2009). Genetic variants associated with Lp(a) lipoprotein level and coronary disease. *New England Journal of Medicine*doi:10.1056/NEJMoa0902604